HUTCHMED (China) Ltd
LSE:HCM
HUTCHMED (China) Ltd
Operating Income
HUTCHMED (China) Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
HUTCHMED (China) Ltd
LSE:HCM
|
Operating Income
$18.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Operating Income
HK$2.6B
|
CAGR 3-Years
14%
|
CAGR 5-Years
22%
|
CAGR 10-Years
29%
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Operating Income
¥3.2B
|
CAGR 3-Years
36%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
S
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Operating Income
¥6.5B
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
17%
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Operating Income
¥1.4B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
19%
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Operating Income
HK$12.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
See Also
What is HUTCHMED (China) Ltd's Operating Income?
Operating Income
18.4m
USD
Based on the financial report for Dec 31, 2023, HUTCHMED (China) Ltd's Operating Income amounts to 18.4m USD.